Reduced number of treatment sessions required: assessed by 1 RCT (N=230), 3 prospective case series studies (N=991), and 1 retrospective case note review (N=319).
Delay in treatment: assessed by 1 RCT (N=230), 3 prospective case series studies (N=991), and 2 retrospective case note reviews (N=1,124).
Prompt treatment: assessed by 1 RCT (N=230), 3 prospective case series studies (N=991), and 2 retrospective case note reviews (N=1,124).
Reduced pressure on out-patient clinics: assessed by 1 RCT (N=230) and 2 prospective case series studies (N=1,861).
Recovery and recovery time: assessed by 1 RCT (N=230) and 2 prospective case series studies (N=791).
Higher patient assessment of progress: assessed by 1 RCT (N=230) and 2 prospective case series studies (N=991).
Lower financial cost to patient: assessed by 1 prospective case series study (N=401).
Health service costs: assessed by 1 prospective case series study (N=390).
There is little evidence to suggest that the number of sessions required for patients referred by direct access is reduced. Direct access significantly reduces the waiting times for treatment compared to referral via a consultant. Consultant referral seems to be reduced where direct access is available. Variable results between studies were found regarding patients own assessment of treatment, and recovery time. The financial cost to patients was lowest where a physiotherapist was provided by the GP.